A Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations in Participants With Moderate-to-Severe Atopic Dermatitis
Abroad (travel likely)Recruiting
Conditions
Atopic Dermatitis · Eczema
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Aarhus University Hospital, Aarhus, Denmark, Denmark
Contact: Principal Investigator (Dr. Christian Vestergaard)